TY - JOUR
T1 - Management of infections caused by antibiotic-resistant streptococcus pneumoniae
AU - Friedland, Ian R.
AU - Mccracken, George H.
PY - 1994/8/11
Y1 - 1994/8/11
N2 - The resistance of Streptococcus pneumoniae to penicillin and other antimicrobial agents is increasing in many parts of the world. The frequency of erythromycin resistance in parts of Europe1 and, to a lesser extent, in the United States2 limits the usefulness of macrolide antibiotics for the treatment of pneumonia, and resistance to trimethoprim-sulfamethoxazole, chloramphenicol, and tetracycline is an important problem in some other countries3,4. Recently, resistance to and clinical failure of the extended-spectrum cephalosporins ceftriaxone and cefotaxime in the treatment of pneumococcal meningitis have been noted in Spain5,6 and the United States7,8. In addition, there have.
AB - The resistance of Streptococcus pneumoniae to penicillin and other antimicrobial agents is increasing in many parts of the world. The frequency of erythromycin resistance in parts of Europe1 and, to a lesser extent, in the United States2 limits the usefulness of macrolide antibiotics for the treatment of pneumonia, and resistance to trimethoprim-sulfamethoxazole, chloramphenicol, and tetracycline is an important problem in some other countries3,4. Recently, resistance to and clinical failure of the extended-spectrum cephalosporins ceftriaxone and cefotaxime in the treatment of pneumococcal meningitis have been noted in Spain5,6 and the United States7,8. In addition, there have.
UR - http://www.scopus.com/inward/record.url?scp=0027956204&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027956204&partnerID=8YFLogxK
U2 - 10.1056/NEJM199408113310607
DO - 10.1056/NEJM199408113310607
M3 - Review article
C2 - 8028618
AN - SCOPUS:0027956204
SN - 0028-4793
VL - 331
SP - 377
EP - 382
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 6
ER -